Clinical Trials Logo

Doping in Sport clinical trials

View clinical trials related to Doping in Sport.

Filter by:
  • None
  • Page 1

NCT ID: NCT04574232 Recruiting - Glucocorticoids Clinical Trials

SporTRIA Study: A Multicentre Trial for Excretion Kinetics of Triamcinolone Acetonide Following Sport Related Intra-articular Injections in Knees; Definitions of the Washout Periods

SporTRIA
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Intra-articular and peri-articular glucocorticoid (GC) injections are common in sports medicine. However, from 1st January 2022, all injectable GC routes (including intra-articular administration (IA)) will be prohibited in-competition by World Anti-Doping Agency (WADA). Due to these rules, an IA GC treatment out-of-competition could result in an adverse analytical finding (AAF) in-competition if the washout period is not clearly defined. The aim of this study is to determine the urinary excretion profile of triamcinolone acetonide following IA to help in the definition of the washout periods.

NCT ID: NCT04203992 Not yet recruiting - Clinical trials for Performance Enhancing Product Use

Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes

Start date: November 2020
Phase: N/A
Study type: Interventional

The purpose of this research is to test the effectiveness of an interactive doping education videogame among student athletes. Specifically, the game will teach athletes aged 13-16 years about the risks of doping and will foster the values, motivation, and behavioural skills needed to avoid temptation and pressure to dope. The investigators hypothesize that student athletes who play the intervention game will have lower use of banned substances and sport supplements, greater intentions to stay clean, and will also show improvements in the cognitive and motivational antecedents to doping when compared to a control condition.